Log in to save to my catalogue

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73192750

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

About this item

Full title

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

Publisher

Heidelberg: Springer

Journal title

European journal of clinical pharmacology, 2003-04, Vol.58 (12), p.809-812

Language

English

Formats

Publication information

Publisher

Heidelberg: Springer

More information

Scope and Contents

Contents

The effect of MDR1 C3435T single nucleotide polymorphism (SNP) in exon 26 on digoxin pharmacokinetics has recently been challenged. OBJECTIVE. To clarify the relationships between MDR1 genetic polymorphisms in exon 26 (C3435T) and 21 (G2677T/A) and digoxin pharmacokinetics.
MDR1 genotypes for C3435T and G2677T/A SNPs were determined in 32 health...

Alternative Titles

Full title

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_73192750

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73192750

Other Identifiers

ISSN

0031-6970

E-ISSN

1432-1041

DOI

10.1007/s00228-003-0567-5

How to access this item